Mauvais-Jarvis F, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–82. https://doi.org/10.1016/S0140-6736(20)31561-0.

Article  PubMed  PubMed Central  Google Scholar 

Bhargava A, et al. Considering sex as a biological variable in basic and clinical studies: an Endocrine Society scientific statement. Endocr Rev. 2021;42(3):219–58. https://doi.org/10.1210/endrev/bnaa034.

Article  PubMed  PubMed Central  Google Scholar 

Dzobo K, et al. Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine. Stem Cells Int. 2018;2018:1–24. https://doi.org/10.1155/2018/2495848.

Article  CAS  Google Scholar 

Mohapatra S, et al. Biomedical application, patent repository, clinical trial and regulatory updates on hydrogel: an extensive review. Gels. 2021;7(4):207. https://doi.org/10.3390/gels7040207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Acharya B, Behera A, Behera S, Moharana S. Recent advances in nanotechnology-based drug delivery systems for the diagnosis and treatment of reproductive disorders. ACS Appl Bio Mater. 2024;7(3):1336–61. https://doi.org/10.1021/acsabm.3c01064.

Article  CAS  PubMed  Google Scholar 

Dayan N, et al. Severe maternal morbidity in women with high BMI in IVF and unassisted singleton pregnancies. Hum Reprod. 2018;33(8):1548–56. https://doi.org/10.1093/humrep/dey224.

Article  CAS  PubMed  Google Scholar 

Karam M, Najjar H, El Sabban M, Hamade A, Najjar F. Regenerative medicine for polycystic ovary syndrome: stem cell-based therapies and brown adipose tissue activation. Stem Cell Rev Rep. 2023;19(4):853–65. https://doi.org/10.1007/s12015-023-10505-5.

Article  PubMed  Google Scholar 

Swingle KL, Ricciardi AS, Peranteau WH, Mitchell MJ. Delivery technologies for women’s health applications. Nat Rev Bioeng. 2023;1(6):408–25. https://doi.org/10.1038/s44222-023-00040-w.

Article  CAS  Google Scholar 

Miller VM. Introduction for sex differences in physiology. In: sex differences in physiology, Elsevier, 2016, pp 1–3. https://doi.org/10.1016/B978-0-12-802388-4.00001-X.

Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143–57. https://doi.org/10.2165/00003088-200948030-00001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allegra S, Chiara F, Di Grazia D, Gaspari M, De Francia S. Evaluation of sex differences in preclinical pharmacology research: how far is left to go? Pharmaceuticals. 2023;16(6):786. https://doi.org/10.3390/ph16060786.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cvitanović Tomaš T, Urlep Ž, Moškon M, Mraz M, Rozman D. LiverSex computational model: sexual aspects in hepatic metabolism and abnormalities. Front Physiol. 2018; 9. https://doi.org/10.3389/fphys.2018.00360.

Kanani K, Gatoulis S, Voelker M. Influence of differing analgesic formulations of aspirin on pharmacokinetic parameters. Pharmaceutics. 2015;7(3):188–98. https://doi.org/10.3390/pharmaceutics7030188.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ochs HR, Greenblatt DJ, Divoll M, Abernethy DR, Feyerabend H, Dengler HJ. Diazepam kinetics in relation to age and sex. Pharmacology. 1981;23(1):24–30. https://doi.org/10.1159/000137524.

Article  CAS  PubMed  Google Scholar 

Cooper SF, Drolet D, Dugal R. Comparative bioavailability of two oral formulations of flurazepam in human subjects. Biopharm Drug Dispos. 1984;5(2):127–39. https://doi.org/10.1002/bdd.2510050206.

Article  CAS  PubMed  Google Scholar 

Mencke T, et al. Einfluss des Geschlechts auf den Verlauf der neuromuskulären Blockade nach Rocuronium. Anaesthesist. 2000;49(7):609–12. https://doi.org/10.1007/s001010070077.

Article  CAS  PubMed  Google Scholar 

Greenblatt DJ, Shader RI, Franke K, Maclaughlin DS, Ransil BJ, Weser JK. Kinetics of intravenous chlordiazepoxide: sex differences in drug distribution. Clin Pharmacol Ther. 1977;22(6):893–903. https://doi.org/10.1002/cpt1977226893.

Article  CAS  PubMed  Google Scholar 

del Carrasco-Portugal CM, Flores-Murrieta FJ. Gender differences in the oral pharmacokinetics of Fluconazole. Clin Drug Investig. 2007;27(12):851–5. https://doi.org/10.2165/00044011-200727120-00007.

Article  CAS  PubMed  Google Scholar 

Madla CM, Gavins FKH, Merchant HA, Orlu M, Murdan S, Basit AW. Let’s talk about sex: differences in drug therapy in males and females. Adv Drug Deliv Rev. 2021;175:113804. https://doi.org/10.1016/j.addr.2021.05.014.

Article  CAS  PubMed  Google Scholar 

Carcas AJ, et al. Gender differences in the disposition of metronidazole. Int J Clin Pharmacol Ther. 2001;39(05):213–8. https://doi.org/10.5414/CPP39213.

Article  CAS  PubMed  Google Scholar 

Werner U, et al. Gender is an important determinant of the disposition of the loop diuretic torasemide. J Clin Pharmacol. 2010;50(2):160–8. https://doi.org/10.1177/0091270009337514.

Article  CAS  PubMed  Google Scholar 

Anderwald C, et al. Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab. 2011;96(2):515–24. https://doi.org/10.1210/jc.2010-1398.

Article  CAS  PubMed  Google Scholar 

Færch K, Pacini G, Nolan JJ, Hansen T, Tura A, Vistisen D. Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs. Diabetes Care. 2013;36(11):3691–7. https://doi.org/10.2337/dc13-0592.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004;44(1):499–523. https://doi.org/10.1146/annurev.pharmtox.44.101802.121453.

Article  CAS  PubMed  Google Scholar 

Lee MY, Kim EJ, Shin A, Kim YS. How to study the sex and gender effect in biomedical research? Korean J Gastroenterol. 2021;77(3):104–14. https://doi.org/10.4166/kjg.2021.020.

Article  PubMed  PubMed Central  Google Scholar 

Makkar RR et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA: J Am Med Assoc. 1993;270(21):2590. https://doi.org/10.1001/jama.1993.03510210076031.

Parekh A, Fadiran EO, Uhl K, Throckmorton DC. Adverse effects in women: implications for drug development and regulatory policies. Expert Rev Clin Pharmacol. 2011;4(4):453–66. https://doi.org/10.1586/ecp.11.29.

Article  PubMed  Google Scholar 

Sager PT, Nebout T, Darpo B. ICH E14: a new regulatory guidance on the clinical evaluation of QT/QTc internal prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Drug Inf J. 2005;39(4):387–94. https://doi.org/10.1177/009286150503900407.

Article  Google Scholar 

Arya A. Gender‐related differences in ventricular repolarization: beyond gonadal steroids. J Cardiovasc Electrophysiol. 2005;16(5):525–7. https://doi.org/10.1111/j.1540-8167.2005.40845.x.

Article  PubMed  Google Scholar 

Gan TJ, et al. Women emerge from general anesthesia with propofol/alfentanil/nitrous oxide faster than men. Anesthesiology. 1999;90(5):1283–7. https://doi.org/10.1097/00000542-199905000-00010.

Article  CAS  PubMed  Google Scholar 

Eugene AR, Masiak J. A pharmacodynamic modelling and simulation study identifying gender differences of daily olanzapine dose and dopamine D2-receptor occupancy. Nord J Psychiatry. 2017;71(6):417–24. https://doi.org/10.1080/08039488.2017.1314011.

Article  PubMed